Table 4 Frequency of clinical follow-up consultations and blood tests of patients treated with NOACs
Frequency | Clinical | Creatinine | INR | Liver enzymes | Haemoglobin |
|---|---|---|---|---|---|
Never | 2 (3.8%) | 2 (3.8%) | 46 (86.8%) | 21 (39.6%) | 14 (26.4%) |
Once | 0 (0%) | 3 (5.7%) | 3 (5.7%) | 2 (3.8%) | 3 (5.7%) |
Monthly | 1 (1.9%) | 2 (3.8%) | 0 (0%) | 2 (3.8%) | 2 (3.8%) |
Every 2–3 months | 35 (66%) | 17 (31.2%) | 1 (1.9%) | 4 (7.5%) | 11 (20.8%) |
Every 6 months | 13 (24.5%) | 21 (39.6%) | 0 (0%) | 10 (18.8%) | 15 (28.3%) |
Annually | 2 (3.8%) | 8 (15.1%) | 3 (5.7%) | 14 (26.4%) | 8 (15.1%) |